Anti-tumour Immunity and Immunotherapy for Cancer Flashcards
How are cancer cells different from normal cells
- Rapid uncontrolled growth
- Increase mobility
- Invade tissue
- Evade immune system
- Metastasize
How does the immune system play an integral role in cancer
- Imbalance in the immune system in a critical contributory factor.
- Immunodeficiency lead to tumour formation eg. kaposi sarcoma, lymphoma.
- Inflammatory conditions lead to cancers too eg. ulcerative colitis and colon cancer
- Tumours infiltrated with lymphocytes have a better prognosis.
How was it discovered that CD8 cells can cure cancer (mouse experiment)
- Mouse treated with methylcholanthrene and induce a sarcoma
- Surgically remove the tumour mass and culture the cells
- When tumour placed in same mouse it didn’t grow
- When the tumour placed in an identical mouse the tumour grows
- When tumour placed in identical mouse with CD8 cells the tumour doesn’t grow
Describe tumour immunosurveillance
- Immunosurveillance’ coined by Burnet & Thomas in 1957 to describe a process where the immune system, namely lymphocytes, continually recognise cancerous and pre cancerous cells leading to their elimination before they can cause damage.
- But Tumours do develop highlighting the fact that immunosurveillance is not perfect.
What are the 3 phases of immunoediting (immunosurveillance)
- Elimination
- Equilibrium
- Escape
Describe the elimination phase
- NKs, NKTs, Macs and DCs (Innate).
- INFγ and chemokines lead to tumour death.
- Tumour specific DCs activate adaptive immunity in draining lymph nodes.
- Tumour specific CD4+ and CD8+ T cells join.
Describe the equilibrium phase
- Elimination phase is incomplete.
- Tumour cells lie dormant and may modulate tumour antigen expression and stress signals.
- The immune system eliminates susceptible tumour clones when possible sufficient to prevent tumour expansion.
- Tumour heterogeniety resulting in ‘Darwinian selection’
Describe the escape phase
Immune system is unable to control the tumour growth leading to tumour progression
How is BCG being used to treat cancers
- Vaccine for TB
- Good immunological adjuvant
- Stimulates the innate immune system TLRs
- Used in bladder cancer- intravesicular injection
- MOA? DC activation, direct NK activation, bystander T cell activation.
How can we use cytokines be used to treat cancer - Interferons
- Type I interferon (a and b)
- Produced by virally infected cells
- Viral detection pathways within most cells
- Upregulates MHC Class 1, tumour antigens and adhesion molecules.
- Activates T cells, B cells and DC
- Used successfully in metastatic melanoma
- Nasty side-effects (‘flu-like symptoms)
How is interleukin-2 to treat cancer
- It is a T cell growth factor
- Success in RCC and melanoma
- Toxicity
- LAK cells, PBMC treated with IL-2 and re-infused into patients
How are GM-CSF being used to treat cancer
- GM-CSF stimulates APC
- Trialled in melanoma, evidence of some success
- May be of benefit if used in conjunction with IL-2
- Other used include: IL-1; IL-4; IL-7; IL-12; gIFN.
How can we use antibody therapy to target tumours
- Direct tumour cell killing
- Immune-mediated tumour cell killing
- Vascular and stromal cell ablation
How doe growth factor blocking work and what agents are used
- Trastuzumab (Herceptin) targets ERBB2 (human epidermal growth factor) on breast cancer cells. Blocks ERBB2 signalling and allows targetting of ADCC
- Bevacizumab (Avastin) targets VEGF and blocks signalling. Used against colon cancer, NSCLC, glioblastoma and kidney cancer.
How can we induce apoptosis and what agents are used
- Rituximab: anti CD20, used for CD20 positive B cell Non Hodgkin’s Lymphoma and Chronic Lymphocytic Lymphoma.
- Alemtuzumab (Campath): anti CD52, used for B-CLL
- They target all B cells which can reduce normal immune function